312 related articles for article (PubMed ID: 32299257)
1. Cell therapy for type 1 diabetes.
Loretelli C; Assi E; Seelam AJ; Ben Nasr M; Fiorina P
Expert Opin Biol Ther; 2020 Aug; 20(8):887-897. PubMed ID: 32299257
[TBL] [Abstract][Full Text] [Related]
2. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
3. Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells.
Dave SD; Vanikar AV; Trivedi HL; Thakkar UG; Gopal SC; Chandra T
Clin Exp Med; 2015 Feb; 15(1):41-5. PubMed ID: 24317657
[TBL] [Abstract][Full Text] [Related]
4. Targeting Stem Cell-Derived Tissue-Associated Regulatory T Cells for Type 1 Diabetes Immunotherapy.
Haque M; Das JK; Xiong X; Song J
Curr Diab Rep; 2019 Aug; 19(10):89. PubMed ID: 31471667
[TBL] [Abstract][Full Text] [Related]
5. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus.
Vanikar AV; Trivedi HL; Thakkar UG
Cytotherapy; 2016 Sep; 18(9):1077-86. PubMed ID: 27424148
[TBL] [Abstract][Full Text] [Related]
6. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
Cierpka-Kmiec K; Wronska A; Kmiec Z
Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
[TBL] [Abstract][Full Text] [Related]
7. Stem cell-derived tissue-associated regulatory T cells suppress the activity of pathogenic cells in autoimmune diabetes.
Haque M; Lei F; Xiong X; Das JK; Ren X; Fang D; Salek-Ardakani S; Yang JM; Song J
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30777937
[TBL] [Abstract][Full Text] [Related]
8. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
[TBL] [Abstract][Full Text] [Related]
9. Toward cell-based therapy of type I diabetes.
Kabelitz D; Geissler EK; Soria B; Schroeder IS; Fändrich F; Chatenoud L
Trends Immunol; 2008 Feb; 29(2):68-74. PubMed ID: 18182324
[TBL] [Abstract][Full Text] [Related]
10. Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective.
Yu H; Paiva R; Flavell RA
Immunology; 2018 Feb; 153(2):161-170. PubMed ID: 29155454
[TBL] [Abstract][Full Text] [Related]
11. Bioprinting and Cellular Therapies for Type 1 Diabetes.
Ravnic DJ; Leberfinger AN; Ozbolat IT
Trends Biotechnol; 2017 Nov; 35(11):1025-1034. PubMed ID: 28789815
[TBL] [Abstract][Full Text] [Related]
12. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
Cabello-Olmo M; Araña M; Radichev I; Smith P; Huarte E; Barajas M
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561568
[TBL] [Abstract][Full Text] [Related]
13. Cell Therapy for Type 1 Diabetes: Current and Future Strategies.
Aghazadeh Y; Nostro MC
Curr Diab Rep; 2017 Jun; 17(6):37. PubMed ID: 28432571
[TBL] [Abstract][Full Text] [Related]
14. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
[TBL] [Abstract][Full Text] [Related]
15. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
Dadheech N; James Shapiro AM
Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
[TBL] [Abstract][Full Text] [Related]
16. Treatment of insulin-dependent diabetes by hematopoietic stem cell transplantation.
Nikoonezhad M; Lasemi MV; Alamdari S; Mohammadian M; Tabarraee M; Ghadyani M; Hamidpour M; Roshandel E
Transpl Immunol; 2022 Dec; 75():101682. PubMed ID: 35926800
[TBL] [Abstract][Full Text] [Related]
17. Recent trends and advances in type 1 diabetes therapeutics: A comprehensive review.
Singh A; Afshan N; Singh A; Singh SK; Yadav S; Kumar M; Sarma DK; Verma V
Eur J Cell Biol; 2023 Jun; 102(2):151329. PubMed ID: 37295265
[TBL] [Abstract][Full Text] [Related]
18. From islet transplantation to beta-cell regeneration: an update on beta-cell-based therapeutic approaches in type 1 diabetes.
Azad A; Altunbas HA; Manguoglu AE
Expert Rev Endocrinol Metab; 2024 May; 19(3):217-227. PubMed ID: 38693782
[TBL] [Abstract][Full Text] [Related]
19. β-Cell replacement as a treatment for type 1 diabetes: an overview of possible cell sources and current axes of research.
Vieira A; Courtney M; Druelle N; Avolio F; Napolitano T; Hadzic B; Navarro-Sanz S; Ben-Othman N; Collombat P
Diabetes Obes Metab; 2016 Sep; 18 Suppl 1():137-43. PubMed ID: 27615143
[TBL] [Abstract][Full Text] [Related]
20. Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?
Bourgeois S; Sawatani T; Van Mulders A; De Leu N; Heremans Y; Heimberg H; Cnop M; Staels W
Cells; 2021 Jan; 10(1):. PubMed ID: 33477961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
